ES2127106A1 - Derivados benzopiranicos con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de los mismos. - Google Patents

Derivados benzopiranicos con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de los mismos.

Info

Publication number
ES2127106A1
ES2127106A1 ES09600682A ES9600682A ES2127106A1 ES 2127106 A1 ES2127106 A1 ES 2127106A1 ES 09600682 A ES09600682 A ES 09600682A ES 9600682 A ES9600682 A ES 9600682A ES 2127106 A1 ES2127106 A1 ES 2127106A1
Authority
ES
Spain
Prior art keywords
group
leukotriene
benzopyran derivatives
so2nr
ch2o
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09600682A
Other languages
English (en)
Other versions
ES2127106B1 (es
Inventor
Casellas David Mauleon
Avellana Jaime Pascual
Perez M Luisa Garcia
Benet Albert Palomer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Menarini SA
Original Assignee
Laboratorios Menarini SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES009600682A priority Critical patent/ES2127106B1/es
Application filed by Laboratorios Menarini SA filed Critical Laboratorios Menarini SA
Priority to HU9901326A priority patent/HUP9901326A3/hu
Priority to EE9800318A priority patent/EE03526B1/xx
Priority to CA002249402A priority patent/CA2249402C/en
Priority to EP97914280A priority patent/EP0888327B1/en
Priority to US09/142,922 priority patent/US5990142A/en
Priority to ES97914280T priority patent/ES2176719T3/es
Priority to BR9708215-5A priority patent/BR9708215A/pt
Priority to KR10-1998-0707399A priority patent/KR100378892B1/ko
Priority to SK1272-98A priority patent/SK282979B6/sk
Priority to UA98094930A priority patent/UA65535C2/uk
Priority to CNB971931933A priority patent/CN1182129C/zh
Priority to IL12629697A priority patent/IL126296A/en
Priority to PT97914280T priority patent/PT888327E/pt
Priority to NZ331953A priority patent/NZ331953A/xx
Priority to AU21587/97A priority patent/AU707282B2/en
Priority to DE69713300T priority patent/DE69713300T2/de
Priority to EA199800738A priority patent/EA001680B1/ru
Priority to PCT/EP1997/001418 priority patent/WO1997034885A1/en
Priority to SI9730340T priority patent/SI0888327T1/xx
Priority to JP53315997A priority patent/JP3914575B2/ja
Priority to AT97914280T priority patent/ATE219073T1/de
Priority to DK97914280T priority patent/DK0888327T3/da
Priority to CZ0299598A priority patent/CZ296260B6/cs
Priority to PL97329027A priority patent/PL189562B1/pl
Priority to TR1998/01857T priority patent/TR199801857T2/xx
Priority to GEAP19974493A priority patent/GEP20012416B/en
Priority to BG102775A priority patent/BG63433B1/bg
Priority to NO19984330A priority patent/NO319612B1/no
Priority to YUP-407/98A priority patent/RS49588B/sr
Priority to CU1998130A priority patent/CU22777A3/es
Publication of ES2127106A1 publication Critical patent/ES2127106A1/es
Priority to HK99103747A priority patent/HK1018701A1/xx
Application granted granted Critical
Publication of ES2127106B1 publication Critical patent/ES2127106B1/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/54—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition of compounds containing doubly bound oxygen atoms, e.g. esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

Derivados benzopiránicos con acción antagonista de los leucotrienos, procedimiento para su preparación y utilización de los mismos. La invención describe derivados de fórmula I, A es un átomo de oxígeno, azufre o un grupo metileno; B y C son: a) cuando B es un heterociclo benzofusionado, U es un átomo de oxígeno, azufre o nitrógeno, Z-Y son átomos de carbono unidos por un enlace doble o sencillo y T es un enlace sencillo, un grupo metileno o carbonilo, C puede ser un grupo -CON{sup,7 R-, CSNR{sup,7 -, SO{sub,2 NR{sup,7 -, CH{sub,2 O-, -CH=CH-; b) cuando B es un grupo fenilo, C puede ser un grupo -SO{sub,2 NR{sup,7 -, CH{sub,2 O-, -CH=CH-; D es un grupo 5-tetrazolilo o -COOR{sup,8 , R{sup,8 es hidrógeno, (C{sub,1 -C{sub,4 )-alquilo o un grupo fenilalquilo; m y n son enteros entre 0 y 4. Presentan acción antagonista de los leucotrienos. Son utilizados como antiinflamatorios, antialérgicos o para tratamiento de enfermedades cardiovasculares.
ES009600682A 1996-03-21 1996-03-21 Derivados benzopiranicos con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de los mismos. Expired - Lifetime ES2127106B1 (es)

Priority Applications (32)

Application Number Priority Date Filing Date Title
ES009600682A ES2127106B1 (es) 1996-03-21 1996-03-21 Derivados benzopiranicos con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de los mismos.
SI9730340T SI0888327T1 (en) 1996-03-21 1997-03-20 Benzopyran derivatives having leukotriene-antagonistic action
EA199800738A EA001680B1 (ru) 1996-03-21 1997-03-20 Производные бензопирана, обладающие антагонистическим действием в отношении лейкотриена
EE9800318A EE03526B1 (et) 1996-03-21 1997-03-20 Leukotrieen-antagonistliku toimega bensopüraanderivaadid, nende valmistamismeetod ja kasutamine
US09/142,922 US5990142A (en) 1996-03-21 1997-03-20 Benzopyran derivatives having leukotriene-antagonistic action
ES97914280T ES2176719T3 (es) 1996-03-21 1997-03-20 Derivados de benzopirano que tienen una accion antagonista de leucotrienos.
BR9708215-5A BR9708215A (pt) 1996-03-21 1997-03-20 Derivados de benzopirano contendo ação antagonista de leucotrieno.
KR10-1998-0707399A KR100378892B1 (ko) 1996-03-21 1997-03-20 류코트리엔-길항활성을갖는벤조피란유도체
SK1272-98A SK282979B6 (sk) 1996-03-21 1997-03-20 Benzopyránové deriváty, spôsob ich prípravy a ich použitie
UA98094930A UA65535C2 (en) 1996-03-21 1997-03-20 Benzopyran derivatives and a method for the preparation thereof
CNB971931933A CN1182129C (zh) 1996-03-21 1997-03-20 具有白细胞三烯拮抗作用的苯并吡喃衍生物
IL12629697A IL126296A (en) 1996-03-21 1997-03-20 Benzopyran derivatives having leukotriene antagonistic action, their preparation and pharmaceutical compositions containing them
PT97914280T PT888327E (pt) 1996-03-21 1997-03-20 Derivados de benzopirano que possuem uma accao antagonistica dos leucotrienos
NZ331953A NZ331953A (en) 1996-03-21 1997-03-20 Benzopyran derivatives having leukotriene-antagonistic action
AU21587/97A AU707282B2 (en) 1996-03-21 1997-03-20 Benzopyran derivatives having leukotriene-antagonistic action
DE69713300T DE69713300T2 (de) 1996-03-21 1997-03-20 Benzopyran derivate mit leukotrien-antagonistischer wirkung
HU9901326A HUP9901326A3 (en) 1996-03-21 1997-03-20 Benzopyran derivatives having leukotriene-antagonistic action, pharmaceutical compositions containing these compounds, process for the preparation and use of these compounds and compositions
EP97914280A EP0888327B1 (en) 1996-03-21 1997-03-20 Benzopyran derivatives having leukotriene-antagonistic action
PCT/EP1997/001418 WO1997034885A1 (en) 1996-03-21 1997-03-20 Benzopyran derivatives having leukotriene-antagonistic action
JP53315997A JP3914575B2 (ja) 1996-03-21 1997-03-20 ロイコトリエンアンタゴニスト作用を有するベンゾピラン誘導体
AT97914280T ATE219073T1 (de) 1996-03-21 1997-03-20 Benzopyran derivate mit leukotrien- antagonistischer wirkung
DK97914280T DK0888327T3 (da) 1996-03-21 1997-03-20 Benzopyranderivater, som har antagonistisk virkning imod leukotriener
CZ0299598A CZ296260B6 (cs) 1996-03-21 1997-03-20 Benzopyranové deriváty, zpusob jejich výroby a farmaceutický prostredek
PL97329027A PL189562B1 (pl) 1996-03-21 1997-03-20 Pochodne benzopiranu o działaniu antagonistycznymdla leukotrienu i sposób ich wytwarzania
TR1998/01857T TR199801857T2 (xx) 1996-03-21 1997-03-20 L�kotrien-antagonistik etkisine sahip olan benzopiran t�revleri.
GEAP19974493A GEP20012416B (en) 1996-03-21 1997-03-20 Benzopyran Derivatives Having Leukotriene-Antagonistic Action
CA002249402A CA2249402C (en) 1996-03-21 1997-03-20 Benzopyran derivatives having leukotriene-antagonistic action
BG102775A BG63433B1 (bg) 1996-03-21 1998-09-17 Бензопиранови производни, имащи антагонистично действие спрямо левкотриени
NO19984330A NO319612B1 (no) 1996-03-21 1998-09-17 Benzopyranderivater som har leukotrien-antagonistisk virkning, fremgangsmate for fremstilling og anvendelse derav
YUP-407/98A RS49588B (sr) 1996-03-21 1998-09-18 Derivati benzopirana koji poseduju leukotrien-antagonističko dejstvo
CU1998130A CU22777A3 (es) 1996-03-21 1998-09-18 Derivados de benzopirano que tienen acción antagonista para el leucotrieno
HK99103747A HK1018701A1 (en) 1996-03-21 1999-08-31 Benzopyran derivatives having leukotriene-antagonistic action.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009600682A ES2127106B1 (es) 1996-03-21 1996-03-21 Derivados benzopiranicos con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de los mismos.

Publications (2)

Publication Number Publication Date
ES2127106A1 true ES2127106A1 (es) 1999-04-01
ES2127106B1 ES2127106B1 (es) 1999-11-16

Family

ID=8294261

Family Applications (2)

Application Number Title Priority Date Filing Date
ES009600682A Expired - Lifetime ES2127106B1 (es) 1996-03-21 1996-03-21 Derivados benzopiranicos con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de los mismos.
ES97914280T Expired - Lifetime ES2176719T3 (es) 1996-03-21 1997-03-20 Derivados de benzopirano que tienen una accion antagonista de leucotrienos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES97914280T Expired - Lifetime ES2176719T3 (es) 1996-03-21 1997-03-20 Derivados de benzopirano que tienen una accion antagonista de leucotrienos.

Country Status (31)

Country Link
US (1) US5990142A (es)
EP (1) EP0888327B1 (es)
JP (1) JP3914575B2 (es)
KR (1) KR100378892B1 (es)
CN (1) CN1182129C (es)
AT (1) ATE219073T1 (es)
AU (1) AU707282B2 (es)
BG (1) BG63433B1 (es)
BR (1) BR9708215A (es)
CA (1) CA2249402C (es)
CU (1) CU22777A3 (es)
CZ (1) CZ296260B6 (es)
DE (1) DE69713300T2 (es)
DK (1) DK0888327T3 (es)
EA (1) EA001680B1 (es)
EE (1) EE03526B1 (es)
ES (2) ES2127106B1 (es)
GE (1) GEP20012416B (es)
HK (1) HK1018701A1 (es)
HU (1) HUP9901326A3 (es)
IL (1) IL126296A (es)
NO (1) NO319612B1 (es)
NZ (1) NZ331953A (es)
PL (1) PL189562B1 (es)
PT (1) PT888327E (es)
RS (1) RS49588B (es)
SI (1) SI0888327T1 (es)
SK (1) SK282979B6 (es)
TR (1) TR199801857T2 (es)
UA (1) UA65535C2 (es)
WO (1) WO1997034885A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60039120D1 (de) 1999-11-24 2008-07-17 Univ New York State Res Found Katalytische rnas mit aminoacylierender aktivität
ATE437946T1 (de) * 2002-02-15 2009-08-15 Univ New York State Res Found Ribozyme mit breiter trna-aminoacylierungswirkung
US7851486B2 (en) 2002-10-17 2010-12-14 Decode Genetics Ehf. Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment
WO2004035741A2 (en) * 2002-10-17 2004-04-29 Decode Genetics Ehf. Susceptibility gene for myocardial infarction; methods of treatment
ITTO20030140U1 (it) * 2003-09-16 2005-03-17 Interfila Srl Matita cosmetica
US7470798B2 (en) 2003-09-19 2008-12-30 Edison Pharmaceuticals, Inc. 7,8-bicycloalkyl-chroman derivatives
CN100475781C (zh) * 2004-02-13 2009-04-08 沃尼尔·朗伯有限责任公司 雄激素受体调节剂
BRPI0507670A (pt) * 2004-02-13 2007-07-17 Warner Lambert Co moduladores do receptor de androgênio
WO2005100305A1 (en) 2004-04-13 2005-10-27 Warner-Lambert Company Llc Androgen modulators
BRPI0513020A (pt) * 2004-07-08 2008-04-22 Warner Lambert Co moduladores de andrÈgenio, seus usos, composição farmacêutica, formulação farmacêutica tópica e artigo de fabricação
CA2573457A1 (en) * 2004-08-18 2006-02-23 Warner-Lambert Company Llc 4-(2-methoxy-phenoxy)-2-trifluoromethyl-benzonitrile as an androgen modulator
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators
US20090170886A1 (en) * 2005-08-08 2009-07-02 Pfizer Inc Androgen modulators
US8188260B2 (en) * 2005-12-06 2012-05-29 The University Of Tokyo Versatile acylation catalytic RNAs and uses thereof
ITMI20061606A1 (it) * 2006-08-09 2008-02-10 Dipharma Spa Procedimento per la preparazione di composti nitrilici
CN102304052A (zh) * 2011-07-28 2012-01-04 浙江大学 一种制备5-溴-2-羟基-3-硝基苯乙酮的方法
CN103980257B (zh) * 2014-05-28 2016-04-27 苏州开元民生科技股份有限公司 8-硝基-2-四氮唑基-4-羰基苯并吡喃的合成方法
CN104402711A (zh) * 2014-11-12 2015-03-11 平湖优康药物研发有限公司 一种抗哮喘药物普伦斯特中间体的合成工艺
CN113651788B (zh) * 2021-09-16 2023-11-21 东华理工大学 一种3-胺烷基色酮化合物及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0395144A (ja) * 1989-08-04 1991-04-19 Ono Pharmaceut Co Ltd アミノフェノール誘導体の製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4977162A (en) * 1989-07-13 1990-12-11 Rorer Pharmaceutical Corporation Quinolinyl-chromone derivatives and use for treatment of hypersensitive ailments

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0395144A (ja) * 1989-08-04 1991-04-19 Ono Pharmaceut Co Ltd アミノフェノール誘導体の製造方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, Vol. 115, no 17, 1991, abstract 182817, pagina 874 & JP 03095144 A (ONO PHARMA) 19.04.1991 *

Also Published As

Publication number Publication date
HUP9901326A3 (en) 2000-12-28
WO1997034885A1 (en) 1997-09-25
KR20000064682A (ko) 2000-11-06
JP2000506878A (ja) 2000-06-06
EP0888327A1 (en) 1999-01-07
KR100378892B1 (ko) 2005-11-14
IL126296A (en) 2002-08-14
CN1182129C (zh) 2004-12-29
YU40798A (en) 1999-11-22
SK282979B6 (sk) 2003-01-09
CA2249402A1 (en) 1997-09-25
EE9800318A (et) 1999-04-15
NO319612B1 (no) 2005-08-29
PL189562B1 (pl) 2005-08-31
BR9708215A (pt) 2000-01-04
SK127298A3 (en) 1999-03-12
EE03526B1 (et) 2001-10-15
PL329027A1 (en) 1999-03-01
CA2249402C (en) 2006-10-24
HK1018701A1 (en) 1999-12-30
HUP9901326A2 (hu) 1999-08-30
CU22777A3 (es) 2002-07-24
CZ299598A3 (cs) 1999-03-17
US5990142A (en) 1999-11-23
DK0888327T3 (da) 2002-09-16
NO984330L (no) 1998-10-09
GEP20012416B (en) 2001-04-25
CZ296260B6 (cs) 2006-02-15
AU707282B2 (en) 1999-07-08
BG63433B1 (bg) 2002-01-31
TR199801857T2 (xx) 1998-12-21
ATE219073T1 (de) 2002-06-15
EP0888327B1 (en) 2002-06-12
BG102775A (en) 1999-08-31
EA199800738A1 (ru) 1999-06-24
NO984330D0 (no) 1998-09-17
SI0888327T1 (en) 2002-10-31
JP3914575B2 (ja) 2007-05-16
AU2158797A (en) 1997-10-10
ES2127106B1 (es) 1999-11-16
IL126296A0 (en) 1999-05-09
DE69713300D1 (de) 2002-07-18
PT888327E (pt) 2002-11-29
CN1214048A (zh) 1999-04-14
DE69713300T2 (de) 2002-09-26
EA001680B1 (ru) 2001-06-25
NZ331953A (en) 1999-03-29
UA65535C2 (en) 2004-04-15
RS49588B (sr) 2007-06-04
ES2176719T3 (es) 2002-12-01

Similar Documents

Publication Publication Date Title
ES2127106A1 (es) Derivados benzopiranicos con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de los mismos.
WO2003010135A1 (fr) Nouveaux derives de l'acide phenylpropionique
ATE485258T1 (de) Glycyrrhetinsäurederivate und ihre verwendung zur herstellung eines medikaments zur hemmung der 11- beta-hydroxysteroid dehydrogenase
MA26861A1 (fr) Inhibiteurs non peptidiques de la liaison cellulaire sous la dependance de vla-4 utiles dans le traitement des maladies inflammatoires, auto-immunes et respiratoires
DE3783988D1 (de) Zyklische enolderivate, herstellung und anwendung.
AP9701039A0 (en) Derivatives of 2- (2-oxo-ethlidene)-imidazolidin-4-one.
BG104853A (en) Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
ATE154937T1 (de) Steroide zur behandlung von prostatisch- hypertrophe, ihre herstellung und verwendung
NO20005671D0 (no) Metabolitter av ecteinascidin 743
ATE106077T1 (de) Zyklopenta(d>pyrimidinderivate, ihre herstellung und verwendung.
DE69202120D1 (de) Harnstoffderivate, ihre Herstellung und ihre Verwendung bei der Therapie.
AU6700590A (en) 1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1- piperazinyl-2-propanones and their use in treatment of neurogenic bladder disorders
HUP0000894A2 (hu) Szubsztituált (1,3-bisz(ciklohexilmetil)-1,2,3,6-tetrahidro-2,6-dioxo-9H-purin-8-il)fenil-származékok és eljárás előállításukra
NO994659L (no) Nye pyridinderivater og farmasöytiske preparater inneholdende slike
EP0609441A4 (en) Oxazolidone derivative.
EP1122252A4 (en) CONDENSED HEREROCYCLIC NITROGEN COMPOUNDS; MANUFACTURING PROCESS AND AGENTS CONTAINING THEM
ATE66476T1 (de) Thianaphthen-derivate, ihre herstellung und verwendung.
DE3671012D1 (de) 5-alkylsulfonylsalicylanilide und mikrobizide zusammensetzungen fuer die regulierung des wachstums von mikroorganismen.
ATE144768T1 (de) Octahydronaphthalenoxim derivate für die inhibierung der cholesterin biosynthese, ihre herstellung und verwendung
ATE64921T1 (de) Benzochinonderivate, ihre herstellung und verwendung.
WO2001035938A3 (de) Pharmakologisch aktive tetrahydrothiopyran-4-ol-derivate, verfahren zu ihrer herstellung und verwendung
EP0773219A4 (en) IMIDAZOQUINOLEIN DERIVATIVE
EP1410822A4 (en) ZOLIDINE OXA (THIA) COMPOUNDS, PREPARATION PROCESS THEREFOR, AND ANTI-INFLAMMATORY AGENTS.
AU2224795A (en) Ameliorant or remedy for paraneoplastic syndrome
ES2117551A1 (es) Quinolinas naftalenicas con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de las mismas.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19990401

Kind code of ref document: A1

Effective date: 19990401